Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines.

Namiot, Eugenia D; Sokolov, Aleksandr V; Chubarev, Vladimir N; Tarasov, Vadim V; Schiöth, Helgi B

Namiot, Eugenia D; Sokolov, Aleksandr V; Chubarev, Vladimir N; Tarasov, Vadim V; Schiöth, Helgi B.

Afiliación

Namiot ED; Department of Neuroscience, Functional Pharmacology, Uppsala University, 75237 Uppsala, Sweden.
Sokolov AV; Department of Neuroscience, Functional Pharmacology, Uppsala University, 75237 Uppsala, Sweden.
Chubarev VN; Advanced Molecular Technology, Limited Liable Company (LLC), 354340 Moscow, Russia.
Tarasov VV; Advanced Molecular Technology, Limited Liable Company (LLC), 354340 Moscow, Russia.
Schiöth HB; Department of Neuroscience, Functional Pharmacology, Uppsala University, 75237 Uppsala, Sweden.

Int J Mol Sci ; 24(1)2023 Jan 02.

Article en En | MEDLINE | ID: mdl-36614230

Asunto(s)

COVID-19; Nanopartículas; Humanos; Vacunas contra la COVID-19/uso terapéutico; COVID-19/prevención & control; Liposomas; Lípidos

Palabras clave

clinical trials; clinicaltrials.gov; liposomes; nanoparticles

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nanopartículas / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google